Skip to main content

View full-text article in PMC

. 2008 Apr 11;7(2):157–166. doi: 10.1093/ecam/nen025

Table 3.

Distribution of patient characteristics of the combined study MAMMA

Prognostic variables			MAMMA		Test
			Iscador	Control	P
			n = 264	n = 264
Matching variables	FIGO	TNM			0.99^b
	I	T1N0M0	53	53
	IIA	T2N0M0	25	26
	IIB	T3N0M0	32	31
		T2N1M0	3	3
	III	T4N0M0	16	16
	IIIA	T2N2M0	5	5
		T3N2M0	5	5
	IIIB	T1-3N3M0	6	6
		T4N1-4M0	36	36
	IV	TXNXM1	83	83
	Menopause				0.99^a
	Prae		28	26
	Post		121	123
	NA		115	115
	Age at first diagnosis				0.97^c
	Mean		54.86	54.84
	SD		8.40	8.51
	Range		32–70	29–70
	Conventional therapy
	Operation		264	264	0.99^a
	Chemotherapy		133	118	<0.01^a
	Radiotherapy		133	135	0.82^a
	Hormone therapy		92	90	0.79^a
Baseline variable	Self-regulation				<0.01^c
	Mean/median		3.87/4.00	3.47/3.55
	SD		1.19	1.01
	Range		1.0–6.0	1.0–6.0
Therapy variable	Iscador use (years)			NA
	Mean/median		4.62/3.00
	SD		4.66
	Range		0.08–23.83

Abbreviations: SD, standard deviation; NA, not available: ^aMN, McNemar test; ^bMH, Marginal homogeneity test; ^cWPS, Wilcoxon paired sample test.